Endoscopy Devices Market By Product Type, By Endoscope Type (Flexible Endoscopes, Rigid Endoscopes, Capsule Endoscopes, Disposable Endoscopes), By Technology, By Application, By End-User - Global Industry Outlook, Key Companies (Olympus Corporation, Stryker Corporation, Karl Storz SE & Co. KG, and Others), Trends and Forecast 2025-2034

Market Overview

The global endoscopy devices market is projected to reach USD 50.8 billion in 2025 and is expected to grow to USD 94.7 billion by 2034, expanding at a CAGR of 7.2%. Growth is driven by rising demand for minimally invasive procedures, advancements in endoscopic imaging technologies, and increasing adoption across gastroenterology, urology, and laparoscopy applications.

Endoscopy devices are medical instruments used to visualize and examine the interior of hollow organs, cavities, or tissues within the human body through minimally invasive techniques. These tools include a combination of endoscopes, cameras, light sources, monitors, and specialized surgical instruments designed to aid in both diagnostic and therapeutic procedures.

By inserting a flexible or rigid tube equipped with a light and a camera through a natural body opening or a small incision, healthcare providers can observe, biopsy, or treat abnormalities in real-time. These devices are integral to modern surgical interventions due to their ability to minimize patient trauma, reduce recovery time, and offer enhanced clinical accuracy. Common procedures using endoscopy include colonoscopy, laparoscopy, bronchoscopy, cystoscopy, and arthroscopy, among others.

The global endoscopy devices market is experiencing significant growth due to the rising demand for minimally invasive surgeries and the increasing prevalence of gastrointestinal, respiratory, and orthopedic disorders. Technological advancements, including high-definition imaging, narrow-band imaging, and the integration of artificial intelligence and robotics, have further enhanced the precision and application range of endoscopic procedures.

Additionally, aging populations, improved healthcare infrastructure, and growing awareness regarding early disease detection are fueling market adoption across both developed and emerging regions. The shift towards outpatient settings and ambulatory surgical centers has also driven the demand for portable and user-friendly endoscopy equipment.

Moreover, the global market is witnessing robust investments in research and development to introduce cost-effective and disposable endoscopy solutions, particularly in environments where infection control is a priority. Companies are focusing on product differentiation, compact design, and automation to meet evolving clinical needs and regulatory standards.

Regions such as North America and Europe currently lead the market, while Asia-Pacific is emerging rapidly due to increasing healthcare spending and favorable government initiatives. The cumulative effect of these drivers is positioning the endoscopy devices market as a key pillar of modern-day diagnostics and therapeutic medicine, with promising future potential in cancer screening, preventive care, and advanced surgical procedures.

The US Endoscopy Devices Market

The U.S. Endoscopy Devices market size is projected to be valued at USD 17.1 billion by 2025. It is further expected to witness subsequent growth in the upcoming period, holding USD 30.8 billion in 2034 at a CAGR of 6.8%.

The United States endoscopy devices market represents one of the most mature and technologically advanced segments globally, driven by a high prevalence of chronic gastrointestinal disorders, colorectal cancer, and respiratory diseases. The widespread adoption of minimally invasive diagnostic procedures, coupled with a strong reimbursement infrastructure, has accelerated the uptake of advanced endoscopic systems across hospitals, ambulatory surgical centers, and specialty clinics.

The growing geriatric population and an increasing emphasis on early detection and preventative healthcare have further boosted the demand for high-definition endoscopy, capsule endoscopy, and robotic-assisted endoscopic surgeries. Additionally, the presence of major players such as Stryker, Boston Scientific, and Medtronic fuels constant innovation in imaging capabilities, ergonomics, and instrument integration, which collectively enhances clinical outcomes and operational efficiency.

Furthermore, the U.S. market benefits from significant investments in research and development, leading to the introduction of AI-enabled diagnostic platforms and single-use endoscopes designed to reduce cross-contamination risks. Hospitals and surgical centers are increasingly adopting disposable and portable endoscopic systems to comply with infection control protocols, particularly in the wake of recent regulatory updates.

Technological innovations such as 3D imaging, virtual endoscopy, and integrated data systems are also gaining traction across specialized procedures like bronchoscopy, arthroscopy, and urological endoscopy. The market's growth trajectory is supported by robust clinical infrastructure, skilled healthcare professionals, and a strong pipeline of FDA-approved endoscopic solutions, positioning the United States as a global leader in endoscopic diagnostics and surgical innovations.

Europe Endoscopy Devices Market

The Europe endoscopy devices market is projected to reach approximately USD 12.7 billion in 2025. This strong foothold is driven by the region’s advanced healthcare infrastructure, widespread availability of specialized endoscopy centers, and early adoption of minimally invasive surgical technologies. Countries like Germany, France, and the UK continue to lead in procedural volumes, supported by favorable reimbursement frameworks and growing awareness of preventive healthcare. Additionally, the increasing prevalence of gastrointestinal disorders and cancer screening programs across Europe is boosting the demand for advanced diagnostic and therapeutic endoscopic systems.

The market is further supported by a rising elderly population that requires frequent medical intervention and by government-funded initiatives promoting non-invasive diagnostic tools. Technological advancements, such as 3D imaging, AI-assisted detection, and robotics-enabled endoscopy, are being swiftly integrated into hospital settings throughout Europe. With a projected CAGR of 6.5% from 2025 to 2034, the European endoscopy devices market is expected to expand steadily, driven by both public health strategies and private sector innovation.

Japan Endoscopy Devices Market

Japan’s endoscopy devices market is estimated to reach around USD 2.1 billion in 2025. The country has a long-standing reputation for excellence in endoscopic technology, largely driven by homegrown giants such as Olympus and Fujifilm. These companies not only dominate the domestic market but also play a central role in global exports.

Japan's strong healthcare infrastructure, combined with an aging population and a high prevalence of gastrointestinal conditions such as colorectal and gastric cancers, significantly fuels the demand for advanced diagnostic and therapeutic endoscopy solutions. Regular nationwide screening programs and a cultural emphasis on early disease detection contribute to high procedural volumes and continued adoption of innovative endoscopic systems.

Moreover, Japan’s healthcare system supports rapid clinical translation of new technologies, allowing seamless integration of AI-enhanced imaging, capsule endoscopy, and minimally invasive surgical techniques into clinical practice. The country’s regulatory framework encourages research and development, creating an ecosystem that fosters continuous innovation. With a projected CAGR of 5.8% between 2025 and 2034, the Japanese endoscopy devices market is expected to grow steadily, supported by technological leadership, increasing procedural complexity, and government support for advancing diagnostic standards across hospitals and specialty clinics.

Global Endoscopy Devices Market: Key Takeaways

• Market Value: The global endoscopy devices market size is expected to reach a value of USD 94.7 billion by 2034 from a base value of USD 50.8 billion in 2025 at a CAGR of 7.2%.

• By Product Type Segment Analysis: Endoscopes are anticipated to dominate the product type segment, capturing 35.0% of the total market share in 2025.
• By Endoscope Type Segment Analysis: High-End Machines are expected to maintain their dominance in the endoscope type segment, capturing 50.0% of the total market share in 2025.
• By Technology Segment Analysis: High Definition (HD) Visualization Systems are expected to consolidate their position in the technology segment, capturing 45.0% of the market share in 2025.
• By Application Segment Analysis: Gastrointestinal (GI) Endoscopy applications will account for the maximum share in the application segment, capturing 35.0% of the total market value.
• By End-User Segment Analysis: Hospitals are expected to consolidate their dominance in the end-user segment, capturing 50.0% of the market share in 2025.
• Regional Analysis: North America is anticipated to lead the global endoscopy devices market landscape with 40.0% of total global market revenue in 2025.
• Key Players: Some key players in the global endoscopy devices market are Olympus, Stryker, Karl Storz, Medtronic, Boston Scientific, Fujifilm, Richard Wolf, Smith & Nephew, Cook Medical, CONMED, Hoya (Pentax Medical), B. Braun, Ethicon (Johnson & Johnson), Zimmer Biomet, Arthrex, Intuitive Surgical, Ambu, Mindray, and Others.

Global Endoscopy Devices Market: Use Cases

• Early Detection of Colorectal Cancer through Colonoscopy: Colonoscopy remains one of the most impactful use cases for endoscopy devices globally, particularly in the early detection and prevention of colorectal cancer. As colorectal cancer ranks among the leading causes of cancer-related deaths worldwide, regular screening using advanced colonoscopy equipment has become standard clinical practice. High-definition (HD) endoscopes equipped with narrow-band imaging (NBI) and virtual chromoendoscopy help gastroenterologists detect polyps, tumors, and abnormal mucosa with greater precision. Innovations such as AI-assisted polyp detection and disposable colonoscopes further enhance diagnostic accuracy while minimizing infection risks. The increasing awareness around colorectal screening programs and government initiatives in countries like the U.S., Germany, and Japan continues to fuel demand for endoscopic procedures in preventive oncology.

• Minimally Invasive Laparoscopic Surgeries in General and Bariatric Surgery: Endoscopy devices play a critical role in enabling minimally invasive laparoscopic surgeries, which are now widely adopted in procedures such as hernia repairs, gallbladder removal, and bariatric surgery. The use of laparoscopes, trocar systems, and endoscopic staplers allows surgeons to perform complex interventions through small incisions, reducing post-operative complications and hospital stays. This use case is especially significant in managing obesity, where laparoscopic sleeve gastrectomy and gastric bypass procedures have shown high success rates. The shift from open to minimally invasive surgery is driven by benefits like reduced recovery time, less blood loss, and improved cosmetic outcomes. Surgeons globally prefer laparoscopic endoscopic equipment due to real-time imaging, ergonomic design, and integration with robotic surgery platforms.
• Pulmonary Diagnosis and Management via Bronchoscopy: Bronchoscopy is a key endoscopic procedure used for diagnosing and managing pulmonary diseases such as chronic obstructive pulmonary disease (COPD), tuberculosis, and lung cancer. Using flexible bronchoscopes equipped with HD video, fluorescence imaging, and biopsy tools, pulmonologists can directly examine the trachea and bronchi to detect tumors, infections, or airway obstructions. The integration of technologies like electromagnetic navigation bronchoscopy (ENB) and robotic-assisted bronchoscopy has improved the ability to reach peripheral lung lesions with minimal invasiveness. In regions with high smoking rates or environmental pollution, the demand for bronchoscopy as a diagnostic and therapeutic tool continues to grow, supporting the broader expansion of the endoscopy devices market.
• Arthroscopic Procedures in Sports Medicine and Orthopedics: Arthroscopy has become a standard technique in orthopedic and sports medicine for diagnosing and treating joint injuries involving the knee, shoulder, hip, and wrist. Endoscopy devices such as rigid arthroscopes, fluid management systems, and shaver instruments allow orthopedic surgeons to visualize joint interiors and perform procedures like ligament repair, cartilage debridement, and synovectomy. These devices are preferred in sports injury treatment due to their ability to enable fast recovery and precise surgical intervention. The rising participation in sports and physical activities, combined with an aging population susceptible to joint degeneration, has significantly boosted the adoption of arthroscopic techniques. With advancements like 4K resolution and integrated light sources, orthopedic endoscopy continues to evolve into a high-growth segment within the global market.

Impact of Artificial Intelligence on the Endoscopy Market

Artificial Intelligence (AI) is revolutionizing the global endoscopy devices market by enhancing diagnostic precision, streamlining workflows, and reducing human error during endoscopic procedures. One of the most significant impacts of AI is in real-time image analysis, particularly in gastrointestinal (GI) endoscopy, where AI-powered software can automatically detect and classify lesions, polyps, and early-stage cancers with high sensitivity and specificity.

These systems use deep learning algorithms trained on vast datasets of endoscopic images, enabling them to support clinicians in making faster and more accurate decisions during procedures like colonoscopy, gastroscopy, and capsule endoscopy. The ability of AI to recognize subtle abnormalities not easily detected by the human eye has made it a game-changer in early cancer detection and preventative diagnostics.

Beyond diagnostics, AI also enhances procedure planning and post-procedure documentation. Machine learning algorithms can assist in mapping out endoscopic navigation paths, reducing procedure time and improving success rates in complex interventions such as bronchoscopy and endoscopic retrograde cholangiopancreatography (ERCP). AI-enabled platforms integrated into endoscopy systems also automate report generation, improving efficiency and consistency in clinical documentation.

Additionally, AI is being integrated into robotic-assisted endoscopy systems, allowing for enhanced maneuverability, stability, and precision during surgical interventions. As regulatory bodies like the FDA approve more AI-powered endoscopy solutions and healthcare institutions prioritize digital transformation, the role of artificial intelligence in the endoscopy devices market is set to expand significantly, transforming patient outcomes and redefining modern endoscopic practices.

Global Endoscopy Devices Market: Stats & Facts

• NHS England Diagnostic Waiting Times and Activity Report

• Endoscopy tests with patients waiting six weeks or more decreased by 8.9 percentage points from March 2023 to March 2024.
• Colonoscopy wait proportions dropped by 12.7 percentage points between March 2023 and March 2024.
• At the end of March 2024, 21.8% of patients were waiting six weeks or more for key diagnostic tests across NHS.
• In March 2023, 25.0% of patients were waiting six or more weeks; by March 2024, that fell to 21.8%.
• No diagnostic test met the operational standard of <1% waiting six weeks or more as of March 2024.

• NHS England Diagnostic Waiting Times January 2023 Report

• At end of January 2023, 486,000 patients (30.8%) waited six weeks or more for key diagnostic tests.
• Compared with January 2022, the number of patients waiting six+ weeks increased by 51,700 and the proportion by 0.8 percentage points.
• Total number of patients waiting at end of January 2023 was 1,580,200, up 129,000 from January 2022.
• 2,174,000 diagnostic tests were performed in January 2023, an increase of 268,000 over January 2022.
• Median average waiting time by end of January 2023 was 2.9 weeks.

• UK Bowel Cancer Screening Standards Data Report (2023–24)

• In England (2023–24), 46.3% (31,229 people) attended their first diagnostic test within 14 days of referral.
• The national target is 90%, but only 46.3% of people met it in 2023–24.
• London’s on-time attendance rate was 53.7%, while South West was lowest at 32.1%.
• The Midlands region achieved 54.7% first-test attendance within 14 days.
• The North West region had a rate of 43.7% on-time attendance.

• NHS Cancer Services Profiles 2023 Annual Update

• In 2022–23, there were 746 colonoscopy procedures per 100,000 population in England.
• 1,121 upper GI endoscopy procedures were performed per 100,000 population in 2022–23.
• Sigmoidoscopy rate was 324 per 100,000 population in 2022–23.
• Urgent suspected cancer referrals reached 4,619 per 100,000 population in 2022–23.
• Detection rate from urgent referrals was 55.6% in 2022–23.

• American Cancer Society / CDC (Colorectal Cancer Facts & Figures & Stat Bite)

• In 2023, in the U.S., an estimated 153,020 new colorectal cancer cases and 52,550 deaths were expected.
• Colorectal cancer is projected to cause 52,900 deaths in the U.S. in 2025.
• New colorectal cancer cases expected in the U.S. in 2025: 154,270.
• The colorectal cancer incidence rate was 37.1 per 100,000 persons (age-adjusted, U.S.).
• The age‑adjusted colorectal cancer death rate was 12.9 per 100,000 persons in the U.S.

Global Endoscopy Devices Market: Market Dynamics

Global Endoscopy Devices Market: Driving Factors

Rising Demand for Minimally Invasive Procedures

The global endoscopy devices market is significantly driven by the increasing preference for minimally invasive surgeries (MIS), which offer faster recovery, reduced post-operative pain, and shorter hospital stays. Endoscopic techniques such as laparoscopy, colonoscopy, and arthroscopy enable physicians to perform diagnostic and therapeutic interventions with minimal tissue disruption. As patient awareness grows and healthcare providers shift toward cost-effective treatment options, the demand for advanced endoscopic systems like high-definition scopes, video processors, and single-use instruments continues to rise across surgical specialties.

Increasing Burden of Chronic Diseases

The growing prevalence of gastrointestinal disorders, colorectal cancer, obesity, and respiratory diseases is fueling the need for accurate and early diagnostic tools. Endoscopy devices are critical in screening and managing these conditions, particularly in aging populations. Enhanced imaging modalities such as narrow-band imaging (NBI) and capsule endoscopy are gaining traction as physicians seek precise visualization of internal structures. The global rise in lifestyle-related illnesses further supports the widespread adoption of GI endoscopy and pulmonary endoscopy procedures.

Global Endoscopy Devices Market: Restraints

High Cost of Advanced Endoscopic Systems

Despite technological innovation, the cost of acquiring and maintaining high-end endoscopy equipment remains a major barrier, especially for smaller clinics and healthcare facilities in low- and middle-income countries. Components such as 4K endoscopic cameras, robotic-assisted systems, and advanced video processors require significant capital investment. Additionally, expenses related to sterilization, technician training, and equipment maintenance raise the total cost of ownership, thereby limiting market penetration in cost-sensitive regions.

Risk of Cross-Contamination and Infections

The risk of infection transmission during reusable endoscope procedures is a critical restraint impacting patient safety and healthcare provider trust. Improper reprocessing and sterilization of flexible endoscopes can lead to hospital-acquired infections (HAIs), increasing scrutiny from regulatory bodies such as the FDA and CDC. This concern has intensified the demand for single-use and disposable endoscopes, yet adoption remains limited due to cost and waste management issues, particularly in large-volume hospitals.

Global Endoscopy Devices Market: Opportunities

Expansion in Emerging Markets

Emerging economies such as India, China, Brazil, and Southeast Asia present a lucrative opportunity for endoscopy device manufacturers. With improving healthcare infrastructure, growing medical tourism, and rising government investment in surgical technologies, these regions are experiencing increased uptake of diagnostic endoscopy and minimally invasive treatment methods. Manufacturers are also tailoring product offerings to suit local needs, such as portable endoscopy units and cost-effective endoscopic solutions, to capture untapped market potential.

Integration of Artificial Intelligence and Robotics

The integration of artificial intelligence (AI) and robotic-assisted endoscopy systems presents significant growth prospects in enhancing procedural accuracy and reducing human error. AI-enabled software for real-time image analysis and lesion detection is improving outcomes in colonoscopy, bronchoscopy, and capsule endoscopy. Additionally, robotic platforms are allowing for better control, precision, and access to hard-to-reach anatomical regions. These innovations open new avenues for smart surgery and next-generation diagnostics, driving future expansion.

Global Endoscopy Devices Market: Trends

Growing Adoption of Disposable and Single-Use Endoscopes

To mitigate infection risks and reduce reprocessing costs, healthcare institutions are increasingly adopting disposable endoscopes, especially in ICU settings and high-risk procedures. Single-use bronchoscopes and ureteroscopes are gaining popularity due to their ability to eliminate cross-contamination, reduce turnaround times, and comply with strict hygiene regulations. This trend is particularly strong in North America and parts of Europe, supported by innovations in material science and compact device engineering.

Technological Advancements in Imaging and Visualization

The endoscopy market is witnessing rapid progress in high-resolution imaging, including 4K ultra-HD video, 3D visualization, and enhanced optical systems. Techniques such as fluorescence imaging, augmented reality overlays, and AI-based tissue recognition are becoming integral to endoscopic procedures. These advancements are improving lesion localization, depth perception, and diagnostic confidence, especially in complex procedures like endoscopic submucosal dissection (ESD) and interventional endoscopy.

Global Endoscopy Devices Market: Research Scope and Analysis

By Product Type Analysis

Endoscopes are expected to lead the product type segment in the global endoscopy devices market, accounting for an estimated 35.0% of the total market share in 2025. This dominance is attributed to their central role in both diagnostic and therapeutic procedures across various medical specialties including gastroenterology, pulmonology, urology, and orthopedics.

The growing preference for minimally invasive surgeries, coupled with the rising incidence of chronic conditions such as colorectal cancer, inflammatory bowel disease, and obesity, has significantly increased the demand for flexible and rigid endoscopes. Technological innovations such as capsule endoscopy, disposable endoscopes, and integration with imaging systems have further strengthened the segment’s growth potential. Hospitals and surgical centers continue to invest in high-quality, durable, and versatile endoscopes that support multiple procedures, thereby contributing to higher procurement rates.

Visualization equipment also plays a crucial role in the endoscopy ecosystem, serving as the technological backbone that supports real-time imaging and enhances procedural accuracy. This segment includes components such as endoscopic cameras, light sources, video processors, and monitors that are essential for transmitting and displaying internal images during surgery.

The increasing adoption of high-definition and 4K imaging systems has significantly improved the clarity and resolution of visuals, enabling early detection of lesions and more precise surgical interventions. As AI-powered image enhancement tools and digital platforms become more integrated into endoscopy suites, the visualization equipment segment is poised for steady growth, driven by the need for better diagnostic confidence and operational efficiency in clinical settings.

By Endoscope Type Analysis

High-end machines are projected to retain their dominance in the endoscope type segment, capturing approximately 50.0% of the total market share in 2025. These systems are equipped with advanced features such as high-definition imaging, enhanced maneuverability, integrated AI-assisted diagnostics, and compatibility with robotic surgical platforms. Their widespread adoption across tertiary care hospitals and specialty surgical centers is driven by the increasing demand for precision, speed, and safety in minimally invasive procedures.

High-end endoscopes are particularly preferred in complex interventions where superior visualization and real-time data integration are crucial, such as in oncology, gastroenterology, and laparoscopic surgeries. The continual upgrades in optical technology, paired with supportive reimbursement frameworks in developed countries, have positioned high-end machines as the preferred choice for healthcare professionals seeking better clinical outcomes and patient satisfaction.

Rigid endoscopes, on the other hand, continue to hold a significant position within the endoscopy market due to their durability, clear imaging capabilities, and effectiveness in specific surgical disciplines. Commonly used in procedures involving orthopedics, gynecology, and urology, rigid endoscopes offer excellent visual clarity and stability, making them ideal for surgeries where straight-line access to the targeted area is possible.

Their mechanical simplicity and ease of sterilization also contribute to their ongoing use, especially in high-volume surgical settings. Despite the rise of flexible and capsule-based technologies, rigid endoscopes remain relevant due to their cost-efficiency and proven effectiveness in interventions like hysteroscopy, cystoscopy, and arthroscopy. Manufacturers continue to improve their design by integrating HD cameras and ergonomic enhancements, ensuring they remain a competitive choice in the broader endoscope category.

By Technology Analysis

High Definition (HD) visualization systems are anticipated to consolidate their leadership in the technology segment of the endoscopy devices market, capturing around 45.0% of the total market share in 2025. These systems provide superior image clarity, enhanced contrast, and finer resolution, which are essential for accurately detecting lesions, identifying anatomical structures, and performing precise interventions. The demand for HD visualization is being driven by its widespread use in procedures such as gastrointestinal endoscopy, laparoscopy, and bronchoscopy, where image quality directly impacts diagnostic accuracy and surgical outcomes.

Healthcare providers are increasingly investing in HD-compatible endoscopic platforms that support high-resolution monitors, advanced video processors, and real-time recording capabilities. Additionally, the integration of HD with other imaging technologies like narrow-band imaging, 3D visualization, and fluorescence endoscopy has further increased its appeal, especially in high-end hospitals and specialized surgical centers.

Standard Definition (SD) systems, while still present in the market, are gradually being phased out as HD and 4K technologies become more accessible and affordable. However, SD systems continue to serve a role in cost-sensitive environments such as small clinics, rural healthcare facilities, and emerging markets where budget constraints and basic diagnostic needs take precedence over advanced imaging.

These systems are typically used for routine procedures that do not require high-detail visualization and are favored for their lower upfront investment and ease of maintenance. Despite limited adoption in technologically advanced settings, SD systems offer a practical solution for facilities aiming to provide basic endoscopic services without the need for premium equipment. Nonetheless, their market share is expected to decline over time as HD technology becomes the new standard in endoscopic imaging.

By Application Analysis

Gastrointestinal (GI) endoscopy is set to account for the largest share in the application segment of the global endoscopy devices market, capturing 35.0% of the total market value in 2025. This dominance is largely driven by the rising global prevalence of GI disorders such as colorectal cancer, peptic ulcers, Crohn’s disease, and irritable bowel syndrome. GI endoscopy, which includes procedures like colonoscopy, gastroscopy, and enteroscopy, plays a vital role in both diagnosis and treatment, allowing physicians to detect abnormalities, perform biopsies, and conduct therapeutic interventions without the need for open surgery.

The growing awareness of preventive healthcare and the importance of early diagnosis, along with increased adoption of high-definition and AI-powered endoscopic systems, has led to a surge in GI screening programs worldwide. The availability of minimally invasive and capsule-based technologies has further expanded access to GI endoscopy in outpatient and ambulatory care settings, reinforcing its dominant position in this market segment.

Laparoscopy also represents a significant portion of the application segment, widely used for surgical interventions in the abdominal and pelvic regions. It is particularly prevalent in procedures such as appendectomy, hernia repair, cholecystectomy, and bariatric surgeries. The key advantage of laparoscopy lies in its minimally invasive nature, which results in shorter hospital stays, faster recovery, and reduced risk of complications.

As obesity rates continue to rise and demand for bariatric procedures increases, laparoscopy has gained substantial traction among surgeons and patients alike. Technological advancements in laparoscopic cameras, energy devices, and robotic-assisted tools have enhanced surgical precision and reduced operator fatigue, making the procedure more efficient and accessible. As more hospitals transition to minimally invasive surgery protocols, laparoscopy is expected to remain a core growth area within the endoscopy devices market.

By End-User Analysis

Hospitals are expected to solidify their leading position in the end-user segment of the global endoscopy devices market, capturing 50.0% of the total market share in 2025. This dominance is primarily due to hospitals' ability to offer a full spectrum of diagnostic and therapeutic endoscopic services under one roof, supported by advanced infrastructure, specialized medical teams, and high patient volumes.

Hospitals are typically the first adopters of new technologies such as high-definition endoscopes, robotic-assisted systems, and AI-powered imaging tools, which further enhance their capability to perform complex and high-risk procedures. Additionally, favorable reimbursement policies and the presence of dedicated departments for gastroenterology, pulmonology, urology, and general surgery make hospitals the preferred setting for both routine and advanced endoscopic procedures. Their centralized procurement processes and integration with research institutions also allow them to stay ahead in clinical innovation and device adoption.

Ambulatory Surgical Centers (ASCs) are emerging as a strong and growing segment within the end-user landscape due to their focus on cost-efficiency, shorter procedure times, and improved patient convenience. ASCs typically handle a wide range of outpatient endoscopic procedures, such as colonoscopy, cystoscopy, and arthroscopy, in a streamlined and low-overhead environment.

The increasing number of minimally invasive procedures being shifted from hospitals to ASCs is driven by advancements in portable endoscopy systems, disposable scopes, and same-day recovery protocols. These centers are especially popular in North America, where value-based care models and patient-centric approaches are gaining momentum. As more healthcare systems prioritize efficiency and affordability, ASCs are expected to capture a larger portion of the market, particularly for elective and preventive diagnostic procedures.

The Endoscopy Devices Market Report is segmented on the basis of the following:

By Product Type

• Endoscopes
• Visualization Equipment
• Endoscopic Operative Devices
• Others

By Endoscope Type

• Flexible Endoscopes
• Rigid Endoscopes
• Capsule Endoscopes
• Disposable Endoscopes

By Technology

• High Definition (HD) Visualization Systems
• Standard Definition (SD) Systems
• 4K/Ultra HD & 3D Endoscopy
• Robotic-Assisted Endoscopy

By Application

• Gastrointestinal (GI) Endoscopy
• Laparoscopy
• Bronchoscopy
• Arthroscopy
• Urology Endoscopy
• Gynecology Endoscopy
• ENT Endoscopy
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Global Endoscopy Devices Market: Regional Analysis

Region with the Largest Revenue Share

North America is anticipated to lead the global endoscopy devices market in 2025, capturing 40.0% of the total market revenue due to its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of key industry players. The region benefits from favorable reimbursement policies, a growing geriatric population, and increased prevalence of gastrointestinal, respiratory, and obesity-related conditions that drive demand for diagnostic and surgical endoscopy.

Additionally, ongoing technological advancements, such as AI-integrated imaging systems and robotic-assisted endoscopy, are rapidly being adopted across hospitals and ambulatory surgical centers, further solidifying North America's leadership in the global market landscape.

Region with significant growth

The Asia-Pacific region is expected to witness the most significant growth in the global endoscopy devices market over the forecast period, driven by rapidly expanding healthcare infrastructure, rising healthcare expenditure, and increasing awareness of early disease detection. Countries like China, India, Japan, and South Korea are experiencing a surge in demand for minimally invasive diagnostic procedures due to the growing burden of gastrointestinal disorders, cancer, and lifestyle-related diseases.

Additionally, the rising adoption of advanced medical technologies, supportive government initiatives, and an expanding base of trained healthcare professionals are further accelerating market penetration. The presence of cost-effective manufacturing and increasing investments from global players looking to tap into emerging markets also contribute to the region’s robust growth potential.

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA

Global Endoscopy Devices Market: Competitive Landscape

The global competitive landscape of the endoscopy devices market is characterized by intense rivalry among leading medical technology companies focused on innovation, strategic partnerships, and portfolio expansion. Key players such as Olympus Corporation, Stryker, Medtronic, Boston Scientific, and Karl Storz dominate the market through continuous product development, AI integration, and expansion into high-growth regions. These companies are investing heavily in high-definition imaging, disposable endoscopes, and robotic-assisted systems to cater to the rising demand for precision and safety in minimally invasive procedures.

Mid-sized and emerging players are also gaining ground by offering cost-effective and specialized solutions tailored to regional needs, particularly in Asia-Pacific and Latin America. The market is further shaped by mergers, acquisitions, and collaborations aimed at strengthening distribution networks and accelerating technological advancements. This dynamic and innovation-driven environment continues to redefine the competitive positioning of companies within the global endoscopy devices industry.

Some of the prominent players in the global endoscopy devices market are:

• Olympus Corporation
• Stryker Corporation
• Karl Storz SE & Co. KG
• Medtronic plc
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Richard Wolf GmbH
• Smith & Nephew plc
• Cook Medical
• CONMED Corporation
• Hoya Corporation (Pentax Medical)
• B. Braun Melsungen AG
• Ethicon Inc. (Johnson & Johnson)
• Zimmer Biomet Holdings, Inc.
• Arthrex, Inc.
• Intuitive Surgical, Inc.
• Ambu A/S
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• SonoScape Medical Corp.
• CapsoVision, Inc.
• Other Key Players

Global Endoscopy Devices Market: Recent Developments

• May 2025: Olympus Corporation launches its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology, part of the EVIS X1 endoscopy system. These advanced scopes (GIF‑EZ1500 and CF‑EZ1500DL/I) provide continuously sharp imaging across the mucosal surface to aid lesion detection with reduced focal adjustments.

• May 2025: Olympus demonstrates its new OLYSENSE cloud-based AI endoscopy platform (CADDIE CADe system) at Digestive Disease Week, supporting cloud connectivity and real-time lesion detection intelligence powered by venture-backed research advances.
• May 2025: The medical device sector raises USD 2.6 billion across 132 venture deals in Q1 2025, marking the highest quarterly volume in three years and signaling strong investor enthusiasm for AI-enabled diagnostic and endoscopic innovations.
• April 2025: Fujifilm announces commercialization of two new gastroscopes (EG‑840T and EG‑840TP) under its ELUXEO 800 Series, offering enhanced visualization through LED multi-light imaging and image-enhanced endoscopy modes like LCI and BLI for upper GI procedures.

Report Details